AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2017
Sep 7, 2017
30786_dirs_2017-09-06_184d4a49-d1ec-4dc6-a9e1-d29fbfd5ed0e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2017-09-05
Reporting Person: HERTIA JOHN (Executive Vice President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-05 | Restricted Stock Units | $0 | A | 3000 | Acquired | Bio-Rad A Common Stock (3000) | Direct | |
| 2017-09-05 | Non-Qualified Stock Option (right to buy) | $215.98 | A | 3000 | Acquired | 2027-09-05 | Bio-Rad A Common Stock (3000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Bio-Rad A Common Stock | 10630 | Direct |
| Bio-Rad A Common Stock | 252 | Indirect |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F2: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.
F3: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13